Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Yersinia pestis is a Gram-negative bacterium and the causative agent of plague. It possesses several virulence factors, including a type III secretion system (T3SS), Yops proteins, LcrV antigen, and yersiniabactin, which contribute to its pathogenicity by suppressing the host's immune response and facilitating iron acquisition. Transmission occurs primarily through flea bites or contact with infected animals or tissues. The bacterium can cause bubonic, septicemic, and pneumonic plague.
Antibiotics target bacterial cell wall synthesis, protein synthesis, or DNA replication to inhibit bacterial growth or kill the bacteria.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Yersinia pestis (Y. pestis).